+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Cytosine Market Size, Share & Trends Analysis Report By End-use (Pharmaceutical, Agriculture, Chemical Industry, and Others), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • January 2024
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5935914
The Asia Pacific Cytosine Market would witness market growth of 9.9% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 247.57 Tonnes, showcasing a growth of 8.9% (2019-2022).

Cytosine and its derivatives play a role in the development of genetically modified crops. Genetic engineering techniques use this compound to modify plant DNA to enhance traits such as resistance to pests, tolerance to environmental stress, and improved nutritional content. As the population continues to rise, an increasing emphasis is on enhancing agricultural productivity. The compound’s role in developing genetically modified crops makes it a crucial component in agricultural biotechnology, contributing to the efficiency and sustainability of food production.

The pharmaceutical industry's relentless pursuit of novel drugs and therapies has led to a surge in the demand for this compound and its derivatives. Researchers are exploring new ways to target specific genes and pathways, driving the need for high-quality cytosine for drug development. The revolutionary CRISPR-Cas9 gene-editing technology has become a game-changer in biotechnology. This compound is a key element in the CRISPR system, and the widespread adoption of this technology has led to an increased demand for this compound in research and therapeutic applications.

China's agriculture sector has witnessed increased productivity by adopting modern farming practices, advanced machinery, and improved crop varieties. The adoption of technology in agriculture, including precision farming, drone applications, and smart farming techniques, has played a crucial role in boosting productivity. China has invested in agricultural technology to improve resource utilization and optimize crop management. Government and private agricultural research and development investments could indirectly impact the market. Research activities may lead to discovering new applications or technologies, creating potential demand for this compound in various fields, including genetic studies and biotechnology. Therefore, the factors mentioned above will propel the market growth in this region.

The China market dominated the Asia Pacific Cytosine Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $39.5 million by 2030. The Japan market is registering a CAGR of 9.1% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 10.5% during (2023 - 2030).

Based on End-use, the market is segmented into Pharmaceutical, Agriculture, Chemical Industry, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
  • VIVAN Life Sciences Pvt. Limited
  • Tokyo Chemical Industry Co. Ltd.
  • Santa Cruz Biotechnology, Inc.
  • FUJIFILM Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
  • Central Drug House (P) Ltd.
  • Naugra Export
  • Marine Chemical

Market Report Segmentation

By End-use (Volume, Tonnes, USD Million, 2019-2030)
  • Pharmaceutical
  • Agriculture
  • Chemical Industry
  • Others
By Country (Volume, Tonnes, USD Million, 2019-2030)
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cytosine Market, by End-use
1.4.2 Asia Pacific Cytosine Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Asia Pacific Cytosine Market, By End-use
4.1 Asia Pacific Pharmaceutical Market, By Country
4.2 Asia Pacific Agriculture Market, By Country
4.3 Asia Pacific Chemical Industry Market, By Country
4.4 Asia Pacific Others Market, By Country
Chapter 5. Asia Pacific Cytosine Market, By Country
5.1 China Cytosine Market
5.1.1 China Cytosine Market, By End-use
5.2 Japan Cytosine Market
5.2.1 Japan Cytosine Market, By End-use
5.3 India Cytosine Market
5.3.1 India Cytosine Market, By End-use
5.4 South Korea Cytosine Market
5.4.1 South Korea Cytosine Market, By End-use
5.5 Singapore Cytosine Market
5.5.1 Singapore Cytosine Market, By End-use
5.6 Malaysia Cytosine Market
5.6.1 Malaysia Cytosine Market, By End-use
5.7 Rest of Asia Pacific Cytosine Market
5.7.1 Rest of Asia Pacific Cytosine Market, By End-use
Chapter 6. Company Profiles
6.1 VIVAN Life Sciences Pvt. Limited
6.1.1 Company Overview
6.2 Central Drug House (P) Ltd.
6.2.1 Company Overview
6.3 Naugra Export
6.3.1 Company Overview
6.4 Marine Chemical
6.4.1 Company Overview
6.5 Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
6.5.1 Company Overview
6.5.2 SWOT Analysis
6.6 Tokyo Chemical Industry Co., Ltd.
6.6.1 Company Overview
6.6.2 SWOT Analysis
6.7 Santa Cruz Biotechnology, Inc.
6.7.1 Company Overview
6.7.2 SWOT Analysis
6.8 FUJIFILM Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.8.5 SWOT Analysis

Companies Mentioned

  • Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
  • VIVAN Life Sciences Pvt. Limited
  • Tokyo Chemical Industry Co. Ltd.
  • Santa Cruz Biotechnology, Inc.
  • FUJIFILM Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
  • Central Drug House (P) Ltd.
  • Naugra Export
  • Marine Chemical

Methodology

Loading
LOADING...